Guidelines & Resources
Why This Work Matters
Research has not advanced evenly across all 16p11.2 variants, leaving gaps in guidance and access. This can be uncomfortable for an organization, but we have chosen to lean into that discomfort and keep an open and respectful dialogue. As a parent- and volunteer-led organization, we work to address these gaps by translating current knowledge into practical care while expanding research, education, and resources.
Our mission is to support all individuals affected by 16p11.2 genetic variation. As the science advances, so will the guidance available to families and clinicians. Please help us advance the science forward for all of our children.
Learn how you can support this work by donating, volunteering, or contributing expertise.
This page is a starting point for clinicians caring for patients with 16p11.2 recurrent deletion. It highlights key takeaways and links you to full, detailed guidance.
Important note: This page is a high‑level summary and navigation tool. It does not replace clinical judgment, specialty consultation, or the original source documents. For full detail, please refer to the linked guidelines and GeneReviews entries.
Start Here
1) GeneReviews (Diagnosis, Management, Surveillance)
16p11.2 Recurrent Deletion (GeneReviews, last updated Oct 28, 2021).
- GeneReviews link: https://www.ncbi.nlm.nih.gov/books/NBK11167 (also mirrored in Europe PMC: https://europepmc.org/article/MED/20301775)
2) Health Supervision Guideline (Primary Care)
Health supervision for children and adolescents with 16p11.2 deletion syndrome (Chung, Herrera, and Simon’s Searchlight, 2023).
- Free full text (PMC): https://pmc.ncbi.nlm.nih.gov/articles/PMC10815286/
- Publisher PDF (Molecular Case Studies): https://molecularcasestudies.cshlp.org/content/9/4/a006316.full.pdf
Purpose: practical health supervision guidance for pediatricians, family physicians, and internists managing the complexities of 16p11.2 deletion in a primary care medical home.
Key Clinical Points At a Glance
Core Phenotype and Common Issues
Common features described in GeneReviews and in the 2023 health supervision review include:
- Developmental delay with variable severity
- Motor speech disorder and language disorder (often prominent)
- Motor coordination difficulties
- Behavioral and psychiatric conditions (high frequency)
- Obesity risk that often emerges in childhood, with BMI divergence reported by early childhood in some cohorts
- Early puberty
- Seizures in about one quarter of individuals
- Additional findings that may occur in some individuals: vertebral anomalies (often linked to scoliosis), hearing impairment, macrocephaly, and cardiac malformations
Diagnosis and Inheritance
- The recurrent BP4–BP5 deletion is defined as a heterozygous ~593 kb deletion (GRCh38 coordinates are described in both the guideline and GeneReviews).
- Diagnosis is typically made by chromosomal microarray or sequencing with copy number variant calling.
- Most cases are de novo, but autosomal dominant inheritance can occur. Parental testing and cascade testing are recommended when a familial deletion is identified.
GeneReviews Quick Use Guide for Clinicians
GeneReviews provides a structured framework for:
- Suggestive findings and diagnostic confirmation methods
- Management, including targeting treatment to identified deficits, neuropsychological assessment, and standard neurologic care for seizures and movement disorders
- Surveillance, including routine monitoring of growth and BMI, developmental progress, educational needs, behavioral assessments, and monitoring for neurologic changes, scoliosis, and hearing loss
When time is limited, GeneReviews can be used as a rapid orientation tool, then paired with the 2023 health supervision guideline for practical visit structure.
Health Supervision Themes from the 2023 Clinical Guidelines
The 2023 health supervision review emphasizes that a multidisciplinary medical home led by primary care and supported by specialists is often the most effective structure.
The guideline also highlights several domains that should be revisited at well visits and at least annually, including neurodevelopmental surveillance and early therapy, nutrition and activity monitoring for obesity risk, and safety planning.
Age-Base Highlights (examples)
Below are examples of recommendations described in the guideline. For full details and age tables, use the source article.
Newborn (birth to 1 month)
- Review family history and prenatal information, and ensure the genetic report is in the medical record when diagnosed prenatally.
- Screen for feeding issues, hearing, vertebral anomalies, and cardiac malformations (echocardiogram).
Infancy (1 month to 1 year)
- Monitor growth and weight, including head circumference and feeding issues.
- Rescreen hearing after newborn screening (the guideline describes a 6-month and annual approach).
- Consider labs when clinically indicated for recurrent infections (CBC with differential and immunoglobulins), and screen for iron deficiency and anemia beginning around one year with annual follow up.
Across childhood
- The guideline repeatedly emphasizes neurocognitive evaluation and early, aggressive therapy when deficits are present.
- Early monitoring of nutrition and activity along with aggressive treatment is encouraged.
Additional Occupational Therapy Guidance
We also share the following Occupational Therapy handbook, which is an exceptionally thorough and practical resource for the 16p11.2 deletion community.
- 16p11.2 Deletion OT Handbook: https://indd.adobe.com/view/0e09e777-bf39-40a3-89b9-6baafaae288f
The 16p11.2 Deletion Syndrome Occupational Therapy Handbook is the doctoral thesis of a PhD student in the OT program at Cal State Dominguez Hills. As a former nanny of a child with 16p11.2 proximal deletion syndrome, she developed the handbook in cooperation with the child’s mother and under the rigorous institutional support and guidance of the university. The handbook explores the syndrome and its clinical manifestations while also explaining occupational therapy practice and evidence-based approaches to address these manifestations. The handbook provides relevant resources and strategies to support families and caregivers. It aims to serve as a foundation for parents and caregivers to explore interventions that may be effective for their child and discover new avenues for exploration, rather than providing definitive strategies for success. The handbook will continue to be updated according to input from members of this community. Version 3 of the handbook will be available soon.
About the OT Handbook
This handbook stands out for its depth, clarity, and real‑world applicability. It translates complex neurodevelopmental and sensory concepts into concrete, actionable strategies, making it useful across settings and developmental stages.
For families, it offers clear explanations, validation of lived experience, and practical guidance that can be used at home, in school, and when advocating for services.
For clinicians and therapists, it provides a comprehensive framework grounded in developmental and neurobiological understanding, with detailed intervention strategies, examples, and considerations specific to 16p11.2 deletion.
Importantly, the handbook bridges the gap between clinical expertise and day‑to‑day function. It supports shared language and shared goals between families and providers, which is essential for coordinated, effective care.
As with all external resources, readers should apply clinical judgment and adapt recommendations to the individual child or patient context.
Use Our Resource Library to Go Deeper
Our Resource Library is a searchable hub that includes:
- Peer‑reviewed papers with brief descriptions
- Reviews and consensus resources
- Reports and books
- Links to trusted organizations and registries
This library is designed to be searched with filters by topic, system, age range, and resource type.
Reminder: Many items are third‑party resources. We do not control their content. Inclusion does not guarantee validity or clinical applicability. Critical appraisal remains the responsibility of the reader.
If you would like to contribute to guideline refinement or specialty pathways, contact the Foundation.